Report for: Comparison of Crocus sativus L. and imipramine in the treatment of mild to moderate depression: A pilot double-blind randomized trial [ISRCTN45683816]

You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.

Title	Comparison of Crocus sativus L. and imipramine in the treatment of mild to moderate depression: A pilot double-blind randomized trial [ISRCTN45683816]
Published in	BMC Complementary and Alternative Medicine, September 2004
DOI	10.1186/1472-6882-4-12
Pubmed ID	15341662
Authors	Shahin Akhondzadeh, Hasan Fallah-Pour, Khosro Afkham, Amir-Hossein Jamshidi, Farahnaz Khalighi-Cigaroudi
Abstract	The morbidity and mortality associated with depression are considerable and continue to increase. Depression currently ranks fourth among the major causes of disability worldwide, after lower respiratory infections, prenatal conditions, and HIV/AIDS. Crocus sativus L. is used to treat depression. Many medicinal plants textbooks refer to this indication whereas there is no evidence-based document. Our objective was to compare the efficacy of stigmas of Crocus sativus (saffron) with imipramine in the treatment of mild to moderate depression in a 6-week pilot double-blind randomized trial.

View on publisher site Alert me about new mentions

Twitter Demographics

The data shown below were collected from the profiles of 21 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Geographical breakdown

Country	Count	As %
Saudi Arabia	9	43%
Kuwait	1	5%
Switzerland	1	5%
Belgium	1	5%
Unknown	9	43%

Demographic breakdown

Type	Count	As %
Members of the public	19	90%
Practitioners (doctors, other healthcare professionals)	2	10%

Mendeley readers

The data shown below were compiled from readership statistics for 193 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country	Count	As %
United Kingdom	1	<1%
Italy	1	<1%
Canada	1	<1%
Australia	1	<1%
Unknown	189	98%

Demographic breakdown

Readers by professional status	Count	As %
Student > Bachelor	31	16%
Student > Master	31	16%
Researcher	31	16%
Other	17	9%
Student > Postgraduate	13	7%
Other	42	22%
Unknown	28	15%

Readers by discipline	Count	As %
Medicine and Dentistry	50	26%
Agricultural and Biological Sciences	30	16%
Pharmacology, Toxicology and Pharmaceutical Science	17	9%
Nursing and Health Professions	15	8%
Biochemistry, Genetics and Molecular Biology	12	6%
Other	33	17%
Unknown	36	19%

Attention Score in Context

This research output has an Altmetric Attention Score of 24. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 January 2020.

All research outputs

#990,156

of 17,424,044 outputs

Outputs from BMC Complementary and Alternative Medicine

#158

of 2,975 outputs

Outputs of similar age

#9,004

of 221,668 outputs

Outputs of similar age from BMC Complementary and Alternative Medicine

#13

of 122 outputs

Altmetric has tracked 17,424,044 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.

So far Altmetric has tracked 2,975 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.7. This one has done particularly well, scoring higher than 94% of its peers.

Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 221,668 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.

We're also able to compare this research output to 122 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.

Comparison of Crocus sativus L. and imipramine in the treatment of mild to moderate depression: A pilot double-blind randomized trial [ISRCTN45683816]

About this Attention Score

Mentioned by

Citations

Readers on

Twitter Demographics

Geographical breakdown

Demographic breakdown

Mendeley readers

Geographical breakdown

Demographic breakdown

Attention Score in Context